<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02094118</url>
  </required_header>
  <id_info>
    <org_study_id>13-005965</org_study_id>
    <nct_id>NCT02094118</nct_id>
  </id_info>
  <brief_title>Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications</brief_title>
  <official_title>Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Blood Systems Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to determine if point-of-care washing of allogeneic Leukocyte-Reduced
      Red Blood Cells reduces pulmonary complications when compared to standard-of-care
      Leukocyte-Reduced Red Blood Cells in a cardiac surgical population.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Biomarkers associated with Transfusion-Related Acute Lung Injury and Transfusion Associated Circulatory Overload.</measure>
    <time_frame>First 24 hours following the index surgical procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of &quot;off-protocol&quot; transfusions</measure>
    <time_frame>Day of surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in recipient hemoglobin</measure>
    <time_frame>Pre to post transfusion (First transfusion), 6 hours, 18 hours, and study day 5 if patient is still in hospital</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in recipient Cell Free Hemoglobin</measure>
    <time_frame>Pre to post transfusion (First transfusion), 6 hours, 18 hours, and study day 5 if patient is still in hospital</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in haptoglobin</measure>
    <time_frame>Pre to post transfusion (First transfusion), 6 hours, 18 hours, and study day 5 if patient is still in hospital</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation</measure>
    <time_frame>Up to hospital day 28, or discharge, whichever comes first</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of oxygen supplementation</measure>
    <time_frame>Up to day 28, or hospital discharge, whichever comes first</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA score</measure>
    <time_frame>Hospital day 28 or discharge, whichever comes first</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Length of Stay</measure>
    <time_frame>Up to day 28</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Off-protocol RBC transfusions (feasibility of point-of-care RBC washing)</measure>
    <time_frame>Within 24 hours of the index surgical procedure</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in the RBC recipient's hemoglobin concentration from pre- to post-transfusion</measure>
    <time_frame>baseline, up to day 5</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in the concentration of neutral lipids from the pre- to the post-wash phase</measure>
    <time_frame>baseline, within 24 hours of the index surgical procedure</time_frame>
    <description>units: mg/dL</description>
  </other_outcome>
  <other_outcome>
    <measure>Development of transfusion-related acute lung injury or transfusion-associated circulatory overload.</measure>
    <time_frame>Up to day 28</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Concentration of cell free hemoglobin following the RBC transfusion</measure>
    <time_frame>Up to Day 5</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Concentration of cell free haptoglobin following the RBC transfusion</measure>
    <time_frame>Up to Day 5</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in the concentration of soluble CD40-ligand (sCD40L) from the pre- to the post-wash phase</measure>
    <time_frame>baseline, within 24 hours of the index surgical procedure</time_frame>
    <description>units: ng/mL</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in the concentration of chemokine (C-C motif) ligand 5/regulated on activation, normal T cell expressed and secreted (CCL5/RANTES) from the pre- to the post-wash phase</measure>
    <time_frame>baseline, within 24 hours of the index surgical procedure</time_frame>
    <description>units: units/mg</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in the concentration of red blood cell microparticles (RBC-MPs) from the pre- to the post-wash phase</measure>
    <time_frame>baseline, within 24 hours of the index surgical procedure</time_frame>
    <description>units: microparticles/ul</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in the concentration of cell-free hemoglobin (CFH) in the RBC component from the pre- to the post-wash phase</measure>
    <time_frame>baseline, within 24 hours of the index surgical procedure</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">170</enrollment>
  <condition>Blood Transfusion Complications</condition>
  <arm_group>
    <arm_group_label>Standard of care red blood cell transfusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Red blood cells that are administered in the normal fashion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Point-of-Care washed red blood cell transfusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Red blood cells that are washed at the point-of-care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Point-of-care washed red blood cell transfusion.</intervention_name>
    <arm_group_label>Point-of-Care washed red blood cell transfusion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Standard of care red blood cell transfusion.</intervention_name>
    <arm_group_label>Standard of care red blood cell transfusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age equal to or greater than 18 years of age.

          -  Scheduled to have cardiac bypass surgery at Mayo Clinic in Rochester, Minnesota or
             Duke University Medical Center in Durham, North Carolina

          -  At risk for needing at least 4 units of blood during/after surgery

        Exclusion Criteria:

          -  Emergency surgery

          -  Immunoglobulin A (IgA) deficiency

          -  History of severe recurrent transfusion reactions

          -  Refusal to receive allogeneic blood products

          -  Refusal to provide informed consent

          -  Prevalent lung injury prior to randomization

          -  Prevalent congestive heart failure prior to randomization

          -  Expected hospital stay &lt; 48 hours

          -  Not anticipated to survive &gt; 48 hours

          -  Previously enrolled in this trial

          -  No plan for placement of a pulmonary artery catheter

          -  Use of home oxygen therapy

          -  Complex RBC antibody profiles

          -  Need for the use of irradiated RBCs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daryl Kor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurie Meade, RN</last_name>
    <phone>507-255-1829</phone>
    <email>meade.laurie@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lavonne M Liedl</last_name>
    <phone>507-255-1828</phone>
    <email>liedl.lavonne@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurie Meade, RN</last_name>
      <phone>507-255-1829</phone>
      <email>meade.laurie@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Lavonne Liedl, RRT</last_name>
      <phone>507-255-1828</phone>
      <email>liedl.lavonne@mayo.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ian Weslby, MBBS</last_name>
      <email>ian.welsby@duke.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 19, 2014</study_first_submitted>
  <study_first_submitted_qc>March 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 21, 2014</study_first_posted>
  <last_update_submitted>August 29, 2017</last_update_submitted>
  <last_update_submitted_qc>August 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Daryl J. Kor, M.D.</investigator_full_name>
    <investigator_title>Associate Professor of Anesthsiology</investigator_title>
  </responsible_party>
  <keyword>Transfusion</keyword>
  <keyword>RBC</keyword>
  <keyword>cardiac</keyword>
  <keyword>surgery</keyword>
  <keyword>transfusion related acute lung injury (TRALI)</keyword>
  <keyword>transfusion associated circulatory overload (TACO)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Transfusion Reaction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

